Ionescu C, Arbore A, Nicola A
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1982 Jul-Sep;31(3):179-86.
The instantaneous prevalence of patients with pulmonary tuberculosis has been evaluated; the patients were included in the dispensarization group I between 1974 and 1980. Initially there was a decrease of the prevalence of the patients in Group I B but over the last years this was stable at 11.7-13.5 0/0000 inhabitants. The decrease which had been obtained at first was due to the immediate effect of repeated treatments with new tuberculostatic drugs resulting in sterilization and inclusion in the Group II of dispensarization of many of the preexisting patients while the ceiling which occurred later was determined by the quantitative balance of therapeutic failures and relapses entering the Group I B and cases which left the Group as a result of medical solutions, death or change of address. It was also noted that most of the patients in whom presence of the bacilli had been determined by microscopic techniques and by cultures constituted a relatively stable group over the entire period of the study, and oscillated between 11 and 17.5%, and 56.5 and 65.9% respectively. The quantitative balance established over the last years between the "entrances" and the "exits" from Group I B may be altered firstly by lowering the number of failures and relapses after the first treatment. The nature of unfavourable factors which influence the prognosis may be classified as follows: bio-psycho-social implications (males--81.5%, age--between 30 and 50 years, 51.4%, lack of occupation, 31.5%, low educational level, 80.1% chronic ethyl intoxication 51.4%, psychoses, 12.7%, other associated diseases, 34.3%, and primary drug resistance, 7.1%); consequences of a late detection; deficiencies in the rhythm and the duration of the first treatment with tuberculostatic drugs (non-cooperation--64.2%, irregularities--38.5%, interruptions--42.8%, secondary drug resistance--14.2%).
对肺结核患者的即时患病率进行了评估;这些患者于1974年至1980年被纳入一级防治组。最初,I B组患者的患病率有所下降,但在过去几年中,该患病率稳定在每10万居民11.7 - 13.5例。起初出现的下降是由于使用新型抗结核药物反复治疗产生的直接效果,导致许多原有患者治愈并被纳入二级防治组,而后来出现的上限是由进入I B组的治疗失败和复发病例与因医疗解决、死亡或地址变更而离开该组的病例之间的数量平衡决定的。还注意到,在整个研究期间,通过显微镜技术和培养确定有杆菌存在的大多数患者构成了一个相对稳定的群体,分别在11%至17.5%和56.5%至65.9%之间波动。过去几年I B组“进入”和“退出”之间建立的数量平衡可能首先会因首次治疗后失败和复发数量的减少而改变。影响预后的不利因素的性质可分类如下:生物 - 心理 - 社会影响(男性占81.5%,年龄在30至50岁之间占51.4%,无职业占31.5%,低教育水平占80.1%,慢性酒精中毒占51.4%,精神病占12.7%,其他相关疾病占34.3%,原发性耐药占7.1%);发现延迟的后果;抗结核药物首次治疗的节奏和持续时间存在缺陷(不合作占64.2%,不规律占38.5%,中断占42.8%,继发性耐药占14.2%)。